You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

recurrent childhood visual pathway and hypothalamic glioma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Refractory Cancer, CNS Tumors, CNS Tumor, Adult Trial in Atlanta, New York (Avutometinib)

Recruiting
  • Refractory Cancer
  • +14 more
  • Atlanta, Georgia
  • +1 more
Oct 23, 2023

Brain Stem Tumor, Pineal Region Tumor, Recurrent Lymphoma Trial in United States (Entinostat, Laboratory Biomarker Analysis,

Completed
Has Results
  • Brain Stem Neoplasm
  • +9 more
  • Birmingham, Alabama
  • +20 more
Jan 6, 2023

Juvenile Pilocytic Astrocytomas, Optic Pathway Gliomas Trial in Atlanta (Pegylated interferon alpha-2b)

Completed
Has Results
  • Juvenile Pilocytic Astrocytomas
  • Optic Pathway Gliomas
  • Pegylated interferon alpha-2b
  • Atlanta, Georgia
    Children's Healthcare of Atlanta
Jan 18, 2022

Neurofibromatosis Type 1, Recurrent Childhood Brain Stem Glioma, Recurrent Childhood Visual Pathway Glioma Trial in United

Completed
  • Neurofibromatosis Type 1
  • +4 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Los Angeles, California
  • +11 more
Apr 22, 2022

Neurofibromatosis Type 1, Recurrent Childhood Pilocytic Astrocytoma, Recurrent Childhood Visual Pathway Glioma Trial in

Active, not recruiting
Has Results
  • Neurofibromatosis Type 1
  • +2 more
  • Birmingham, Alabama
  • +125 more
Jan 25, 2023

Brain and CNS Tumors, Intraocular Melanoma, Lung Cancer Trial in New York (genetic, other, radiation)

Active, not recruiting
  • Brain and Central Nervous System Tumors
  • +9 more
  • DNA analysis
  • +4 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Oct 28, 2021

Optic Pathway Glioma Trial in Rome (CHF6467, Placebo)

Not yet recruiting
  • Optic Pathway Glioma
  • Rome, Italy
    Catholic University, Policlinico A. Gemelli (Hospital)
Feb 17, 2023

Recurrent Low Grade Astrocytoma, Recurrent WHO Grade 2 Glioma, Refractory Low Grade Astrocytoma Trial in Canada, United States

Recruiting
  • Recurrent Low Grade Astrocytoma
  • +4 more
  • Quality-of-Life Assessment
  • +3 more
  • Birmingham, Alabama
  • +64 more
Aug 20, 2022

Pilomyxoid Astrocytoma, Pilocytic Astrocytoma, Glioma, Astrocytic Trial in New Hyde Park (Mebendazole, Vincristine, Carboplatin)

Recruiting
  • Pilomyxoid Astrocytoma
  • +11 more
  • New Hyde Park, New York
    Cohen Children's Medical Center of New York
Mar 3, 2021

Neurofibromatosis Type 1, Plexiform Neurofibroma, Optic Nerve Glioma Trial in London (Selumetinib)

Recruiting
  • Neurofibromatosis Type 1
  • +2 more
  • London, United Kingdom
  • +1 more
Nov 11, 2021

Optic Glioma, Pediatric Brain Tumor, Optic Nerve Glioma Trial in Beijing (Carboplatin, Vincristine, Recombinant human

Recruiting
  • Optic Glioma
  • Pediatric Brain Tumor, Optic Nerve Glioma
  • Beijing, China
    Capital Medical University Sanbo Brain Hospital
Jul 4, 2022

High Grade Glioma, Glioma, Glioma, Malignant Trial in Phoenix (Temsirolimus)

Not yet recruiting
  • High Grade Glioma
  • +3 more
  • Phoenix, Arizona
    St. Joseph's Hospital and Medical Center
Mar 6, 2023

Brain Tumors Trial in San Diego, Atlanta (Poly ICLC)

Completed
  • Brain Tumors
  • Poly ICLC
  • San Diego, California
  • +1 more
Apr 20, 2022

Pontine Glioma Trial in Phoenix, Grand Rapids (Vismodegib)

Terminated
Has Results
  • Pontine Glioma
  • Phoenix, Arizona
  • +1 more
Apr 20, 2022

Iris Color and Day-Night Changes in the Sympathovagal Ratio

Completed
  • Iris Diseases
  • Iris Color Measurement , LF/HF Measurement
  • (no location specified)
Mar 7, 2023

High Grade Glioma, Glioblastoma Multiforme Trial in Japan, United States (DSP-0390)

Recruiting
  • High Grade Glioma
  • Glioblastoma Multiforme
  • San Francisco, California
  • +8 more
Dec 16, 2022

Recurrent Ependymoma, Recurrent Ewing Sarcoma, Recurrent Hepatoblastoma Trial in Puerto Rico, United States (Ivosidenib)

Recruiting
  • Recurrent Ependymoma
  • +32 more
  • Birmingham, Alabama
  • +173 more
Jan 27, 2023

Glioma, High Grade Glioma, Pontine Tumors Trial in Ann Arbor (Dasatinib, Everolimus)

Terminated
Has Results
  • Glioma
  • +2 more
  • Ann Arbor, Michigan
    University of Michigan Cancer Center
Sep 26, 2022

Recurrent Glioblastoma, IDH-Wildtype, Recurrent WHO Grade 2 Glioma, Recurrent WHO Grade 3 Glioma Trial (Biospecimen Collection,

Not yet recruiting
  • Recurrent Glioblastoma, IDH-Wildtype
  • +2 more
  • Biospecimen Collection
  • +2 more
  • (no location specified)
May 13, 2023

Glioma Trial in Spain, United States (LY2157299, Lomustine)

Active, not recruiting
  • Glioma
  • Baltimore, Maryland
  • +3 more
Oct 18, 2022

Hematopoietic and Lymphoid Cell Tumor, Recurrent Ependymoma, Recurrent Ewing Sarcoma Trial in Puerto Rico, United States

Recruiting
  • Hematopoietic and Lymphoid Cell Neoplasm
  • +37 more
  • Birmingham, Alabama
  • +171 more
Aug 24, 2022

CNS Tumors, Medulloblastoma Trial in Worldwide (Pomalidomide)

Active, not recruiting
Has Results
  • Central Nervous System Neoplasms
  • Medulloblastoma
  • Stanford, California
  • +24 more
Sep 28, 2022

Malignant Glioma, Glioblastoma Trial in Durham (Evolocumab)

Recruiting
  • Malignant Glioma
  • Glioblastoma
  • Durham, North Carolina
    Duke University Medical Center
Oct 13, 2022

Glioblastoma, Astrocytoma, Oligodendroglioma Trial (OKN-007)

Withdrawn
  • Glioblastoma
  • +2 more
  • (no location specified)
Oct 5, 2022

Glioblastoma Multiforme, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma Trial in United States (INCB7839)

Recruiting
  • Glioblastoma Multiforme
  • +5 more
  • Los Angeles, California
  • +12 more
Jan 9, 2023